Proposed Introduction of Elective Care Scheme for LLP Copay “Hard to Understand”: Chuikyo Members

Chuikyo General Assembly Meeting on Dec. 1 Japan’s key reimbursement policy panel on December 1 continued to discuss the proposed copay review of off-patent brand-name drugs, called long-listed products (LLPs), but many members complained about the complex nature of the...read more